These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 26341371)
1. Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors. Chamberlain MC; Born D J Neurooncol; 2015 Nov; 125(2):249-51. PubMed ID: 26341371 [TBL] [Abstract][Full Text] [Related]
2. Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors. Srebotnik-Kirbiš I; Limbäck-Stokin C J Neurooncol; 2016 Sep; 129(3):415-422. PubMed ID: 27406587 [TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
4. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Chen H; Thomas C; Munoz FA; Alexandrescu S; Horbinski CM; Olar A; McGuone D; Camelo-Piragua S; Wang L; Pentsova E; Phillips J; Aldape K; Chen W; Iafrate AJ; Chi AS; Zagzag D; Golfinos JG; Placantonakis DG; Rosenblum M; Ohman-Strickland P; Hameed M; Snuderl M Neuro Oncol; 2019 Sep; 21(9):1164-1174. PubMed ID: 31140557 [TBL] [Abstract][Full Text] [Related]
5. A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors. Senetta R; Verdun di Cantogno L; Chiusa L; Castellano I; Gugliotta P; Sapino A; Cassoni P J Neuropathol Exp Neurol; 2013 May; 72(5):432-41. PubMed ID: 23584201 [TBL] [Abstract][Full Text] [Related]
6. Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases. Ren X; Jiang H; Cui X; Cui Y; Ma J; Jiang Z; Sui D; Lin S Neuro Oncol; 2013 Sep; 15(9):1244-50. PubMed ID: 23861470 [TBL] [Abstract][Full Text] [Related]
7. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma. Sathornsumetee S; Cheunsuchon P; Sangruchi T World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282 [TBL] [Abstract][Full Text] [Related]
8. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens. Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068 [TBL] [Abstract][Full Text] [Related]
9. α-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status. Eigenbrod S; Roeber S; Thon N; Giese A; Krieger A; Grasbon-Frodl E; Egensperger R; Tonn JC; Kreth FW; Kretzschmar HA J Neuropathol Exp Neurol; 2011 Nov; 70(11):970-8. PubMed ID: 22002423 [TBL] [Abstract][Full Text] [Related]
10. Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion. Pai T; Epari S; Desai S; Wadile A; Gupta T; Goda JS; Moiyadi A; Shetty P; Kane S; Jalali R Neurol India; 2017; 65(1):113-120. PubMed ID: 28084254 [TBL] [Abstract][Full Text] [Related]
11. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours. Kim JW; Park CK; Park SH; Kim YH; Han JH; Kim CY; Sohn CH; Chang KH; Jung HW J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):224-7. PubMed ID: 20587495 [TBL] [Abstract][Full Text] [Related]
12. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321 [TBL] [Abstract][Full Text] [Related]
13. Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss. Snuderl M; Eichler AF; Ligon KL; Vu QU; Silver M; Betensky RA; Ligon AH; Wen PY; Louis DN; Iafrate AJ Clin Cancer Res; 2009 Oct; 15(20):6430-7. PubMed ID: 19808867 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. Fallon KB; Palmer CA; Roth KA; Nabors LB; Wang W; Carpenter M; Banerjee R; Forsyth P; Rich K; Perry A J Neuropathol Exp Neurol; 2004 Apr; 63(4):314-22. PubMed ID: 15099021 [TBL] [Abstract][Full Text] [Related]
15. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340 [TBL] [Abstract][Full Text] [Related]
16. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic. Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304 [TBL] [Abstract][Full Text] [Related]
17. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A; Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167 [TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH. Talagas M; Marcorelles P; Uguen A; Redon S; Quintin-Roué I; Costa S; Férec C; Morel F; Hieu PD; De Braekeleer M J Neurooncol; 2012 Sep; 109(2):405-13. PubMed ID: 22825724 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. Kouwenhoven MC; Gorlia T; Kros JM; Ibdaih A; Brandes AA; Bromberg JE; Mokhtari K; van Duinen SG; Teepen JL; Wesseling P; Vandenbos F; Grisold W; Sipos L; Mirimanoff R; Vecht CJ; Allgeier A; Lacombe D; van den Bent MJ Neuro Oncol; 2009 Dec; 11(6):737-46. PubMed ID: 19224764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]